TD Waterhouse Canada Inc. Purchases 81,337 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

TD Waterhouse Canada Inc. increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 26.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 384,228 shares of the company's stock after buying an additional 81,337 shares during the quarter. TD Waterhouse Canada Inc. owned 0.08% of GE HealthCare Technologies worth $30,031,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Tower Research Capital LLC TRC raised its holdings in shares of GE HealthCare Technologies by 104.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 38,136 shares of the company's stock valued at $2,981,000 after purchasing an additional 19,467 shares during the last quarter. MML Investors Services LLC increased its stake in GE HealthCare Technologies by 9.8% in the 4th quarter. MML Investors Services LLC now owns 24,899 shares of the company's stock valued at $1,947,000 after buying an additional 2,215 shares during the last quarter. Natixis bought a new stake in GE HealthCare Technologies during the 4th quarter worth about $2,187,000. MetLife Investment Management LLC boosted its stake in shares of GE HealthCare Technologies by 2.0% during the 4th quarter. MetLife Investment Management LLC now owns 122,768 shares of the company's stock worth $9,598,000 after buying an additional 2,407 shares during the last quarter. Finally, Norinchukin Bank The grew its holdings in shares of GE HealthCare Technologies by 14.6% in the 4th quarter. Norinchukin Bank The now owns 24,810 shares of the company's stock valued at $1,940,000 after acquiring an additional 3,166 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

GEHC stock traded up $1.37 during trading hours on Friday, hitting $68.42. 5,508,467 shares of the stock were exchanged, compared to its average volume of 3,250,958. The company has a 50-day simple moving average of $77.07 and a two-hundred day simple moving average of $82.34. The firm has a market capitalization of $31.33 billion, a P/E ratio of 15.80, a P/E/G ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.20%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of a number of analyst reports. Piper Sandler decreased their price target on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a research note on Wednesday. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their price target for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. Finally, Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and a consensus price target of $96.50.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.